N
Namratha
About Namratha
Data last updated:
Namratha is a Company Secretary at Concord Drugs Limited (since 2024) and Additional Director at Paysafecard.Com India Private Limited (since 2025). The companies operate in Pharma, Business Services and Aviation. The 2 current companies with reported revenue have a combined latest revenue of ₹45.54 Cr; the largest is Concord Drugs Limited at ₹45.26 Cr (FY 2025). Earlier, Namratha was a Designated Partner at Vsay Digitech Llp (2023–2025) and Additional Director at Gramam (The Village) Foundation (2024–2025) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Company Secretary | 19 Mar 2024 | 1995 | ₹45.26 Cr (FY 2025) | Active | |
| Additional Director | 01 Jun 2025 | 2020 | ₹27.8 Lakh (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 20 Oct 2023 | 2023 | Active | ||
| Additional Director | 10 Dec 2024 | 2017 | ₹7 Lakh (FY 2020) | Active | |
| Company Secretary | 11 May 2022 | 1994 | ₹68.75 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Namratha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Koni Reddy Seelam | 02829319 | Concord Drugs Limited | Whole-Time Director |
| Koni Reddy Seelam | Concord Drugs Limited | Cfo | |
| Nagavenkatahareeshkumar Solleti | 09066790 | Concord Drugs Limited | Director |
| Nagi Reddy Seelam | 01764665 | Concord Drugs Limited | Managing Director |
| Satyam Reddy Gopidi | 11282375 | Concord Drugs Limited | Director |
| Seelam Manojkumarreddy | 06991382 | Concord Drugs Limited | Whole-Time Director |
| Sumeela Kasu | 09571540 | Concord Drugs Limited | Director |
| Saurabh Ramdorai | 07684410 | Paysafecard.Com India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Namratha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Namratha
Namratha currently holds 2 directorships: Concord Drugs Limited (Company Secretary, since 19 Mar 2024, revenue ₹45.26 Cr (FY 2025)); Paysafecard.Com India Private Limited (Additional Director, since 01 Jun 2025, revenue ₹27.8 Lakh (FY 2023)).
Namratha was first appointed on 11 May 2022 as Company Secretary at Seshachal Technologies Limited. The most recent appointment on record is 01 Jun 2025 at Paysafecard.Com India Private Limited.
The 2 current companies of Namratha that report revenue have a combined latest revenue of ₹45.54 Cr: Concord Drugs Limited ₹45.26 Cr (FY 2025); Paysafecard.Com India Private Limited ₹27.8 Lakh (FY 2023).
Namratha held 3 earlier board appointments: Vsay Digitech Llp (Designated Partner, 20 Oct 2023 to 22 Apr 2025); Gramam (The Village) Foundation (Additional Director, 10 Dec 2024 to 24 Mar 2025); Seshachal Technologies Limited (Company Secretary, 11 May 2022 to 14 Mar 2024).
The current boards of Namratha's companies include Koni Reddy Seelam (Concord Drugs Limited), Koni Reddy Seelam (Concord Drugs Limited), Nagavenkatahareeshkumar Solleti (Concord Drugs Limited), Nagi Reddy Seelam (Concord Drugs Limited), Satyam Reddy Gopidi (Concord Drugs Limited), Seelam Manojkumarreddy (Concord Drugs Limited), among others.